46041-69-4 Usage
Uses
Used in Pharmaceutical Industry:
(S)-2-(PIPERIDIN-2-YL)PYRIDINE is used as a synthetic intermediate for the development of various drugs and active pharmaceutical ingredients (APIs), leveraging its unique structural properties to enhance the therapeutic efficacy of medications.
Used in Medicinal Chemistry:
(S)-2-(PIPERIDIN-2-YL)PYRIDINE is utilized as a building block in the synthesis of heterocyclic compounds, which are integral to the design of novel pharmaceutical agents with diverse biological activities.
Used in Organic Chemistry Reactions:
(S)-2-(PIPERIDIN-2-YL)PYRIDINE serves as a reagent in organic chemistry, contributing to the advancement of chemical processes and the synthesis of complex organic molecules for various applications, including drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 46041-69-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,6,0,4 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 46041-69:
(7*4)+(6*6)+(5*0)+(4*4)+(3*1)+(2*6)+(1*9)=104
104 % 10 = 4
So 46041-69-4 is a valid CAS Registry Number.
46041-69-4Relevant academic research and scientific papers
Cheng, Yan-Qin,Bian, Zheng,Kang, Chuan-Qing,Guo, Hai-Quan,Gao, Lian-Xun
, p. 1572 - 1575 (2008)
Chiral ligand 2-(2′-piperidinyl)pyridine 1 has been synthesized in good overall yield by sequential benzylation, hydrogenation and debenzylation of 2,2′-bipyridine. Its enantiomerically pure enantiomers have been obtained by resolution of 2-(1-benzyl-2-piperidinyl)pyridine 2 with d-tartaric acid (or l-tartaric acid) followed by debenzylation. The absolute configuration was determined by X-ray analysis of the (S)-2 d-tartrate. It was demonstrated that 1 can be used as an effective enantioselective catalyst in the addition of diethylzinc to aldehydes. Optically active secondary alcohols with up to 100% enantiomeric excess were obtained in high yields.